Maxcyte (MXCT) Treasury Shares (2022 - 2025)

Maxcyte (MXCT) has 4 years of Treasury Shares data on file, last reported at $1.8 million in Q4 2025.

• Treasury Shares for Q4 2025 came in at $1.8 million, up 5.97% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 5.97% YoY), and the FY2025 annual result was $1.8 million, up 5.97% from the prior year.
• Treasury Shares rose to $1.8 million in Q4 2025 per MXCT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Treasury Shares peaked at $1.8 million in Q4 2025 and troughed at $643600.0 in Q4 2022.
• A 4-year average of $1.4 million and a median of $1.5 million in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares soared 101.4% in 2023, then increased 5.97% in 2025.
• A 4-year view of Treasury Shares shows it stood at $643600.0 in 2022, then jumped by 101.4% to $1.3 million in 2023, then surged by 31.47% to $1.7 million in 2024, then rose by 5.97% to $1.8 million in 2025.
• Business Quant data shows MXCT's Treasury Shares at $1.8 million in Q4 2025, $1.7 million in Q4 2024, and $1.3 million in Q4 2023.